Geode Capital Management
RKDA icon

Geode Capital Management’s Arcadia Biosciences RKDA Stock Holding History

Geode Capital Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.8K Buy
31,743
+21,088
+198% +$41.3K ﹤0.01% 4346
2025
Q4 		$21.1K Sell
10,655
-2,346
-18% -$8.64K ﹤0.01% 4379
2025
Q3 		$45.1K Buy
13,001
+206
+2% +$842 ﹤0.01% 4315
2025
Q2 		$56.4K Hold
12,795
– – ﹤0.01% 4190
2025
Q1 		$36.3K Buy
12,795
+498
+4% +$2.16K ﹤0.01% 4250
2024
Q4 		$72.8K Buy
+12,297
New +$50.6K ﹤0.01% 4173
2023
Q1 		– Sell
-4,437
Closed -$48K – 4825
2022
Q4 		$48K Sell
4,437
-17
-0.4% -$242 ﹤0.01% 4603
2022
Q3 		$93K Buy
4,454
+49
+1% +$1.67K ﹤0.01% 4602
2022
Q2 		$176K Buy
4,405
+192
+5% +$8.83K ﹤0.01% 4351
2022
Q1 		$235K Hold
4,213
– – ﹤0.01% 4296
2021
Q4 		$175K Hold
4,213
– – ﹤0.01% 4537
2021
Q3 		$348K Buy
4,213
+93
+2% +$8.73K ﹤0.01% 4193
2021
Q2 		$488K Buy
4,120
+1,868
+83% +$204K ﹤0.01% 3957
2021
Q1 		$247K Buy
2,252
+1,023
+83% +$125K ﹤0.01% 4050
2020
Q4 		$124K Hold
1,229
– – ﹤0.01% 4014
2020
Q3 		$137K Hold
1,229
– – ﹤0.01% 3827
2020
Q2 		$184K Hold
1,229
– – ﹤0.01% 3687
2020
Q1 		$139K Buy
1,229
+272
+28% +$47.3K ﹤0.01% 3657
2019
Q4 		$209K Buy
957
+168
+21% +$33.7K ﹤0.01% 3779
2019
Q3 		$147K Buy
789
+445
+129% +$85.3K ﹤0.01% 3864
2019
Q2 		$42K Hold
344
– – ﹤0.01% 4099
2019
Q1 		$96K Buy
+344
New +$71.9K ﹤0.01% 3903
2018
Q1 		– Sell
-66
Closed -$14K – 4070
2017
Q4 		$14K Buy
66
+33
+100% +$7.15K ﹤0.01% 4005
2017
Q3 		$11K Hold
33
– – ﹤0.01% 4038
2017
Q2 		$11K Hold
33
– – ﹤0.01% 4074
2017
Q1 		$17K Hold
33
– – ﹤0.01% 4050
2016
Q4 		$24K Hold
33
– – ﹤0.01% 3987
2016
Q3 		$50K Hold
33
– – ﹤0.01% 3913
2016
Q2 		$67K Sell
33
-10
-23% -$16.7K ﹤0.01% 3879
2016
Q1 		$94 Buy
43
+3
+8% +$6.37K ﹤0.01% 3846
2015
Q4 		$97K Sell
40
-6
-13% -$15.6K ﹤0.01% 3890
2015
Q3 		$112K Buy
+46
New +$191K ﹤0.01% 3869

Other funds holding RKDA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Geode Capital Management's RKDA Position: Q1 2026 in Review

Geode Capital Management increased its Arcadia Biosciences (RKDA) stake by 198% in Q1 2026, buying an estimated $41.3K and bringing the position to 31,743 shares worth $43.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4346.

Geode Capital Management first reported a position in RKDA in Q3 2015 and has held it in 32 quarters since. The position peaked at $488K in Q2 2021. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.

  • Geode Capital Management held 31,743 shares of Arcadia Biosciences worth $43.8K as of Q1 2026.
  • Geode Capital Management bought 21,088 Arcadia Biosciences shares in Q1 2026, an estimated $41.3K.
  • Arcadia Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4346 holding.
  • Geode Capital Management first reported a position in Arcadia Biosciences in Q3 2015 and has held it in 32 quarters since.
  • Geode Capital Management's Arcadia Biosciences position peaked at $488K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.